Open Nav

Please submit your session questions in advance at

Innovate Biopharmaceuticals, Inc.

  • Christopher Prior, Innovate Biopharmaceuticals, Inc

Innovate is a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases with unmet needs. Our pipeline includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis. Innovate is led by a strong management team with extensive drug development experience and a history of bringing novel therapeutics to market. All global rights to the products, which are backed by more than 150 patents worldwide, are owned by the company.

  • Date:Monday, February 11
  • Time:1:45 PM - 2:00 PM
  • Room:Gramercy
  • Location:7th Floor
  • Session Type:Company Presentation
  • Company Presentation - Presentation Type:Publicly Traded Company
  • Submission ID:23633
  • Goal for Presentation:Company Update / Partnership
  • Company
  • Company HQ City:Raleigh
  • Company HQ State:North Carolina
  • Company HQ Country:United States
  • Market Cap:60M
  • Ticker:INNT
  • Exchange:NASDAQ-CM
  • CEO/Top Company Official:Christopher Prior, PhD
  • Year Founded:2012
  • Main Therapeutic Focus:Inflammation
  • Lead Product in Development:INN-202 Celiac Disease
  • Development Phase of Primary Product:Phase III
Christopher Prior
Innovate Biopharmaceuticals, Inc